Pain types and risk factors in post-COVID-19

被引:1
作者
Ketenci, Aysegul [1 ]
Zure, Mert [2 ]
Akpinar, Fatma Merih [3 ,16 ]
Ozdemir, Yelda Soluk [4 ]
Balbaloglu, Oezlem [5 ]
Akaltun, Mazlum Serdar [6 ]
Erden, Ender [7 ]
Turk, Ayla Cagliyan [7 ]
Korkmaz, Merve Damla [2 ]
Okmen, Burcu Metin [8 ]
Altindag, Oezlem [6 ]
Soyupek, Feray [9 ]
Yaksi, Elif [1 ,10 ]
Sindel, Dilsad [3 ]
Sezgin, Nalan [1 ,11 ]
Ustaomer, Kubra [12 ]
Kesiktas, Fatma Nur [4 ]
Dere, Didem [4 ]
Gunes, Sevket [13 ]
Ceylan, Cansin Medin [4 ]
Tur, Birkan Sonel [14 ]
Evcik, Deniz [15 ]
机构
[1] Koc Univ Hosp, Dept Phys Med & Rehabil, TR-34010 Istanbul, Turkiye
[2] Istanbul Kanuni Sultan Suleyman Training & Res Hos, Dept Phys Therapy & Rehabil, Istanbul, Turkiye
[3] Istanbul Univ, Istanbul Fac Med, Dept Phys Med & Rehabil, Istanbul, Turkiye
[4] Istanbul Phys Therapy Rehabil Training & Res Hosp, Dept Phys Med & Rehabil, Istanbul, Turkiye
[5] Yozgat Bozok Univ, Fac Med, Dept Phys Med & Rehabil, Yozgat, Turkiye
[6] Gaziantep Univ, Res Hosp, Dept Phys Med & Rehabil, Gaziantep, Turkiye
[7] Hitit Univ, Fac Med, Dept Phys Med & Rehabil, Corum, Turkiye
[8] Bursa Yuksek Ihtisas Training & Res Hosp, Dept Phys Med & Rehabil, Bursa, Turkiye
[9] Suleyman Demirel Univ, Fac Med, Dept Phys Med & Rehabil, Isparta, Turkiye
[10] Abant Izzet Baysal Univ, Fac Med, Dept Phys Med & Rehabil, Bolu, Turkiye
[11] Medikent Hosp, Dept Phys Med & Rehabil, Luleburgaz, Turkiye
[12] Tekirdag Namik Kemal Univ, Fac Med, Dept Phys Med & Rehabil, Tekirdag, Turkiye
[13] Istanbul Sancaktepe Ilhan Varank Training & Res Ho, Dept Phys Therapy & Rehabil, Istanbul, Turkiye
[14] Ankara Univ, Fac Med, Dept Phys Med & Rehabil, Ankara, Turkiye
[15] Guven Hosp, Dept Phys Med & Rehabil, Ankara, Turkiye
[16] Istanbul Univ, Istanbul Tip Fak, Fiziksel Tip & Rehabil Anabilim Dali, TR-34093 Istanbul, Turkiye
关键词
Central sensitization; neuropathic pain; nociceptive pain; pain; physical activity; post-COVID-19; conditions; RELIABILITY; VALIDITY;
D O I
10.5606/tftrd.2024.13828
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objectives: This study aims to accurately evaluate pain lasting longer than three months and falls under the category of chronic pain and to determine the risk factors to follow up and treat properly and to develop appropriate diagnostic and treatment algorithms. Patients and methods: Between March 2021 and December 2021, a total of 437 patients (162 males, 275 females; mean age: 44 +/- 14.6 years; range, 12 to 82 years) who were referred to the participating centers due to pain complaints and were diagnosed with post-COVID-19 condition according to the criteria defined by the World Health Organization (WHO) were included in the study. The patients were divided into three groups as nociceptive pain, neuropathic pain, and central sensitization, based on the physician's clinical evaluation and the Self-Report Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and Central Sensitization Inventory scores. Results: The most common diagnosis was nociceptive pain followed by central sensitization. Patients with nociceptive pain had less pain. It was found that not exercising regularly, having a chronic disease and being a woman were risk factors for central sensitization, having thyroid disease before COVID-19, and defining the current pain as very severe were risk factors for neuropathic pain. Conclusion: In the evaluation of post-COVID-19 pain, neuropathic pain and central sensitization should be also considered in addition to nociceptive pain and the severity of pain, systemic diseases and physical activity should be questioned.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 20 条
  • [1] Post-COVID syndrome. A case series and comprehensive review
    Anaya, Juan-Manuel
    Rojas, Manuel
    Salinas, Martha L.
    Rodriguez, Yhojan
    Roa, Geraldine
    Lozano, Marcela
    Rodriguez-Jimenez, Monica
    Montoya, Norma
    Zapata, Elizabeth
    Monsalve, Diana M.
    Acosta-Ampudia, Yeny
    Ramirez-Santana, Carolina
    [J]. AUTOIMMUNITY REVIEWS, 2021, 20 (11)
  • [2] Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic
    Attal, Nadine
    Martinez, Valeria
    Bouhassira, Didier
    [J]. PAIN REPORTS, 2021, 6 (01)
  • [3] The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research
    Bennett, MI
    Smith, BH
    Torrance, N
    Potter, J
    [J]. JOURNAL OF PAIN, 2005, 6 (03) : 149 - 158
  • [4] Central Sensitization Phenotypes in Post Acute Sequelae of SARS-CoV-2 Infection (PASC): Defining the Post COVID Syndrome
    Bierle, Dennis M.
    Aakre, Christopher A.
    Grach, Stephanie L.
    Salonen, Bradley R.
    Croghan, Ivana T.
    Hurt, Ryan T.
    Ganesh, Ravindra
    [J]. JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2021, 12
  • [5] Chippa V, 2023, StatPearls
  • [6] Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study
    Fernandez-de-las-Penas, Cesar
    De-la-Llave-Rincon, Ana, I
    Ortega-Santiago, Ricardo
    Ambite-Quesada, Silvia
    Gomez-Mayordomo, Victor
    Cuadrado, Maria L.
    Arias-Navalon, Jose A.
    Hernandez-Barrera, Valentin
    Martin-Guerrero, Jose D.
    Pellicer-Valero, Oscar J.
    Arendt-Nielsen, Lars
    [J]. PAIN, 2022, 163 (09) : E989 - E996
  • [7] Post-COVID Pain Syndromes
    Fiala, Kenneth
    Martens, Joshua
    Abd-Elsayed, Alaa
    [J]. CURRENT PAIN AND HEADACHE REPORTS, 2022, 26 (05) : 379 - 383
  • [8] Is Central Sensitisation the Missing Link of Persisting Symptoms after COVID-19 Infection?
    Goudman, Lisa
    De Smedt, Ann
    Noppen, Marc
    Moens, Maarten
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (23)
  • [9] Keles ED, 2021, ARCH RHEUMATOL, V36, P518, DOI [10.46497/ArchRheumatol.2021.8665, 10.46497/ArchRheumatol.2022.8665]
  • [10] Validity and Reliability of the Turkish Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaire
    Koc, Rabia
    Erdemoglu, A. Kemal
    [J]. PAIN MEDICINE, 2010, 11 (07) : 1107 - 1114